Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems Inc (NQ: OMIC )

0.4074 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4074
Bid (Size) 0.3900 (4)
Ask (Size) 0.4280 (49)
Prev. Close 0.4074
Today's Range 0.4074 - 0.4074
52wk Range 0.3101 - 1.210
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q4 2023
OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Singular Genomics Sys: Q4 Earnings Insights
Via Benzinga

Performance

YTD
-16.00%
-16.00%
1 Month
-19.33%
-19.33%
3 Month
-6.06%
-6.06%
6 Month
+9.22%
+9.22%
1 Year
-59.26%
-59.26%

More News

Read More
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Via Benzinga
Preview: Singular Genomics Sys's Earnings
Via Benzinga
Recap: Singular Genomics Sys Q3 Earnings
Via Benzinga
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Top 5 Health Care Stocks That May Explode In Q3
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.